Group 1 - The core viewpoint of the news is that Beijing Boke Testing System Co., Ltd. has shown positive financial performance with significant revenue and profit growth, alongside active trading activity in its stock [1][2] Group 2 - As of December 19, Boke Testing's stock price increased by 1.18%, with a trading volume of 32.92 million yuan [1] - On December 19, the financing buy amount was 2.57 million yuan, while the financing repayment was 3.25 million yuan, resulting in a net financing buy of -0.68 million yuan [1] - The total balance of margin trading for Boke Testing as of December 19 was 79.74 million yuan, with a financing balance of 79.44 million yuan, accounting for 8.72% of the circulating market value [1] - The company specializes in the research, design, manufacturing, sales, and system integration of servo hydraulic testing equipment and automotive testing equipment, with automotive testing solutions contributing 78.59% to its main business revenue [1] Group 3 - As of December 10, the number of shareholders for Boke Testing was 7,754, a decrease of 0.53%, while the average circulating shares per person increased by 0.53% to 1,898 shares [2] - For the period from January to September 2025, Boke Testing achieved operating revenue of 362 million yuan, representing a year-on-year growth of 12.32%, and a net profit attributable to the parent company of 77.98 million yuan, up 19.60% year-on-year [2] - Since its A-share listing, Boke Testing has distributed a total of 118 million yuan in dividends [2]

Group 1 - The company, Boke Testing (301598), is actively monitoring industry trends related to robot testing and is beginning to make strategic plans in this area [1] - Currently, there are no existing cases of humanoid robot testing [1]

Core Viewpoint - The company, Boke Testing (301598), is actively expanding its global market for high-end testing and experimental equipment, with both domestic and international sales progressing in an orderly manner [1] Group 1 - The company is committed to developing its high-end testing and experimental equipment business [1] - The sales operations for both domestic and international markets are being carried out in an organized manner [1]

Core Viewpoint - The company has confirmed its involvement in the aerospace sector through its servo hydraulic testing systems, while asserting that its automotive testing business is not facing a bottleneck despite industry adjustments and market fluctuations [2][2]. Group 1: Aerospace and Automotive Testing - The company produces servo hydraulic testing systems that are already applied in the aerospace field [2]. - In the automotive testing sector, the company views industry adjustments, market volatility, and increased competition as normal occurrences, indicating that overall business is not experiencing a bottleneck [2].

格隆汇12月19日丨博科测试(301598.SZ)在互动平台表示，公司所生产的伺服液压测试系统，已在航空 航天领域应用；汽车测试方面，行业调整、市场波动、市场竞争加剧等在我们看来都是常态，对公司而 言，整体业务并未遇到瓶颈。 ...

格隆汇12月19日丨博科测试(301598.SZ)在互动平台表示，公司所生产的伺服液压测试系统，已在航空 航天领域应用；汽车测试方面，行业调整、市场波动、市场竞争加剧等在我们看来都是常态，对公司而 言，整体业务并未遇到瓶颈。 ...

Group 1 - The core point of the news is that 博科测试 (Boke Testing) experienced a slight decline in stock price on December 18, with a trading volume of 27.93 million yuan and a net financing purchase of 658,700 yuan [1][2] - As of December 18, the total margin balance for 博科测试 is 80.42 million yuan, with the financing balance accounting for 8.89% of the circulating market value [2] - The company reported a revenue of 362 million yuan for the period from January to September 2025, representing a year-on-year growth of 12.32%, and a net profit attributable to shareholders of 77.98 million yuan, up 19.60% year-on-year [2] Group 2 - 博科测试's main business involves the research, design, manufacturing, sales, and system integration of servo hydraulic testing equipment and automotive testing equipment, with automotive testing solutions contributing 78.59% to its revenue [2] - The company has distributed a total of 118 million yuan in dividends since its A-share listing [3] - As of December 10, the number of 博科测试 shareholders decreased by 0.53% to 7,754, while the average circulating shares per person increased by 0.53% to 1,898 shares [2]

证券代码：301598 证券简称：博科测试 公告编号：2025-062 北京博科测试系统股份有限公司 1、本次上市流通的限售股为北京博科测试系统股份有限公司（以下简称"公 司"或"博科测试"）部分首次公开发行前已发行股份。 2、本次上市流通的限售股份数量为 6,540,917 股，解除限售股东数量为 9 名，占公司总股本的 11.11%，限售期为自公司股票上市之日起 12 个月。 3、本次拟解除限售的股份上市流通日期为：2025 年 12 月 22 日（星期一）。 一、公司股票发行情况 经中国证券监督管理委员会（以下简称"中国证监会"）《关于同意北京博 科测试系统股份有限公司首次公开发行股票注册的批复》（证监许可〔2024〕1299 号）同意注册，公司首次公开发行人民币普通股（A 股）股票 14,724,306 股（以 下简称"本次发行"），并于 2024 年 12 月 20 日在深圳证券交易所创业板上市， 首次公开发行股票完成后公司总股本为 58,897,223 股。其中有限售条件的股票数 量为 44,172,917 股，占发行后总股本的比例为 75%；无限售条件流通股票数量 14,724,306 股，占发 ...

中信证券股份有限公司 关于北京博科测试系统股份有限公司 本次申请解除股份限售的股东共 9 名，公司本次申请解除股份限售的股东在 公司《首次公开发行股票并在创业板上市招股说明书》和《首次公开发行股票并 在创业板上市之上市公告书》中做出的承诺与实际履行情况一致，具体情况如下： 部分首次公开发行前已发行股份上市流通的核查意见 中信证券股份有限公司（以下简称"中信证券"、"保荐人"）作为北京博 科测试系统股份有限公司（以下简称"博科测试"、"公司"）首次公开发行股 票并在创业板上市的保荐人，根据《证券发行上市保荐业务管理办法》《深圳证 券交易所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》等有关规定，对博科测试部分首次公开发行前 已发行股份上市流通的事项进行了审慎核查，具体情况如下： 一、公司股票发行情况 经中国证券监督管理委员会（以下简称"中国证监会"）《关于同意北京博 科测试系统股份有限公司首次公开发行股票注册的批复》（证监许可〔2024〕1299 号）同意注册，公司首次公开发行人民币普通股（A 股）股票 14,724,306 股（以 下简称"本次发行"），并于 2 ...

证券日报网讯12月15日，博科测试（301598）在互动平台回答投资者提问时表示，截至2025年12月10 日，公司股东总户数(合并普通账户和融资融券信用账户)为7754户。 ...